Farmas USA

dentro con 1000 acciones Exel a 4,6
que sea lo que dios quiera.

De falsa alarma nada. A ultima hora ha habido unos paquetones elegantes. Ejemplo 255K de golpe y porrazo. UNo, o la han sujetado o DOS, alguna mano fuerte quiere salirse....

MIrando el konkorde, dice que aunque las manos fuertes siguen saliendo, lo hacen en menor medida por lo que me apoyo mas en la opcion uno.

Ojito cuidador, no te arrepientas de dar acciones a este precio.......

Cierre en 7.20, justo el último máximo más cercano.
El siguiente 7.50
El siguiente 9.07 (Se os cae la baba. Secaros !)

Mañana que?
Yo ahora mismo no tengo ni idea.

A ver si entre todos averiguamos que farma es esta,mi traductor no es lo mejor que tengo, es una alerta de mensaje condicionada,si alguien quiere le puedo mandar el correo,S2
You can also receive his full report on this innovative biotech here...]

a ver si sale bien

!

[Greg’s note: Since the horrors of war helped unlock the secrets to chemotherapy, it remains the go-to treatment for cancer patients across the world.

“While chemo is old news as far as medical technology goes, it’s still a tough technology to improve upon — even with the latest wonder drugs,” says technology correspondent Ray Blanco.

Today, Ray tells the story of a small biotech on his radar that’s doing just that. Instead of developing proprietary technology, this firm has acquired overlooked oncology compounds pioneered by others for use in new treatments.

According to Ray, small firms can quickly commercialize timely acquisitions like this one — jumpstarting sales and profits.

Read on for Ray’s take. You can also receive his full report on this innovative biotech here...]

How Old Technology Will Spawn the Next Generation of Chemotherapy
By Ray Blanco

Sometimes medical revolutions happen under the most unlikely circumstances...

On Dec. 2, 1943, a surprise air raid on the Allied-controlled port of Bari, Italy, was so successful as to receive the name “Little Pearl Harbor.” Among the ships damaged by aerial bombardment were the SS John Harvey and its load of chemical weapons. Fires set off by exploding bombs released tons of deadly chemical warfare agents into the air and water around Bari, exposing thousands of people and producing hundreds of casualties.

This amazing science and wealth story will be pulled off line Midnight Wednesday, May 30 — so you must act fast or else you could miss out....

The Tiny Company Set to Soar...

This one tiny company could have an enormous impact on your wealth. It could also save the life of someone very close to you.

Click here for the full report.

You see, in late 1943, Allied forces had just secured military control of southern Italy in a strategy designed to open a new front against the Axis cancer in the “soft underbelly of Europe.” The tide of war was turning, but the outcome was yet far from certain.

Furthermore, a disturbing fact was known to the Allies. Nations on both sides of the war had signed the Geneva Protocol against the use of chemical weapons. Nazi Germany had, however, developed a large stockpile of potent chemical weapons. If Hitler chose to use them in desperation, the results could be dire. Thoughts of a Luftwaffe raid dropping nerve gas bombs above London’s skies loomed large in the minds of military planners.

Allied powers, therefore, produced chemical weapons of their own as a deterrent against any possible Axis use. Behind the scenes, they also began to move them into the battle space... just in case.

Secretly, the SS John Harvey, a cargo ship loaded with thousands chemical warfare bombs, arrived in the newly captured Italian port of Bari. Located in the south end of the peninsula, Bari had become a major logistical hub for Allies in the Italian campaign.

However, since the Axis air forces were considered to be too thinly stretched to be much of a threat, the port was only lightly defended against aerial attack.

This proved to be a critical miscalculation.

From “Little Pearl Harbor,” however, an opportunity emerged. The U.S. Department of Defense had recently initiated research of possible therapeutic applications for chemical weapon agents. Shortly after the disaster, the U.S. dispatched medical experts to investigate the effects of mustard gas on humans.

A study of the aftermath showed that mustard gas disproportionately suppressed rapidly dividing cell lines responsible for producing blood cells. Yale University researchers later demonstrated that the chemical agents dispersed by the Bari raid could also be used to suppress rapidly dividing cancer cell lines. Chemical agents were to open up a new front in a new war — attacking the cancer’s soft underbelly.

With a boom, the chemotherapy revolution had begun.

Unlock the Secrets of Unlimited Wealth

With this simple strategy you could unlock the secrets of unlimited wealth.

Learn how to decode all the confusion of the stock markets — unearthing plays with multiplying profit potential right here.

Since the discovery at Bari, chemo drugs have become the mainstay in the fight against cancer.

While chemo is old news as far as medical technology goes, it’s still a tough technology to improve upon — even with the latest wonder drugs.

Many biotechnology companies use proprietary technological platforms to move new cancer therapies into market. Some companies, however, use a different approach. They focus on acquiring overlooked yet promising oncology compounds pioneered by others.

The advantage of this approach is that by the time an acquisition is made, a lot of the early work on a compound has already been done. Unlike a biotechnology company developing a new therapeutic platform, a company using existing compounds doesn’t necessarily have to wait a decade or more before seeing revenues.

A smart acquisition that can be commercialized quickly can start generating sales in a fraction of the time...

And that is what is happening today. Take pancreatic cancer for example.

Pancreatic cancer is the deadliest of cancers. Only 6% of people diagnosed with metastatic pancreatic cancer survive to the five-year mark, and the average life expectancy is only three-nine months. Although pancreatic cancer is not among the most common cancer types, its high mortality rate still makes it the fourth-biggest killer overall.

Despite the deadliness of this kind of cancer, we haven’t seen a new first line of defense emerge against it in many years.

Today, the leading drug for treating pancreatic cancer is the chemotherapy compound gemcitabine.

Yesterday, I told my Technology Profits Confidential readers about a biotechnology company using science to teach this old dog a few new tricks. In the process, it holds the potential to unlock billions of dollars’ worth of revenues.

To access the full report, click here.

Ad lucrum per scientia (toward wealth through science),

Ray Blanco

P.S. Before I go, I wanted to share with you some other breakthrough research I stumbled across...

My colleague, Patrick Cox, recently released this new report about one tiny company could have an enormous impact on your wealth. It could also save the life of someone very close to you.

But, this report will be removed TONIGHT at midnight, so I urge you to act fast.

Click here for the full story.

From a World War II Explosion to the Next Generation of Chemotherapy is featured at Penny Sleuth.

Questions or comments? Drop us a line at [email protected].

Yo veo también como puntos estratégicos el 7,4 y el 7,7

Aupa THLD!!

Efectivamente, he comprobado que ya está en ING. Ahora mismo está a 1,78$

Yo tambien estoy dentro, porque lo dijo ENOLA. Que hijo de expresidente tiene 100.000€ dentro??

Estais hablando de SNSS???

Gracias